Marc Beer went to Miami University where he earned a B.S. since then he devoted himself to work at health-related industries such as Angerion, ViaCell and Genzyme company where he has gained extensive experience. At ViaCell Marc Beer contributed to the preservation and collection process of the much umbilical cord and the blood stem cells. Marc Beer also served at Nasdaq: ova as a consultant for some years also making a legacy in the same company. While working at Genzyme Marc Beer held various marketing and sales roles for the Abbott Laboratories. He also used to be a member of the Mass life Science Board as well as in Good Start Genetics. Working in all these companies has earned Marc beer popularity across the globe.
Marc Beer has transformed the lives of many women by devoting his skills and resources to the health sector. He has worked in any health-related companies leading to the establishment of many new treatments for various diseases. Over the years his interest has been in the biotechnology, pharmaceutical and digital diagnostics sectors. Marc Beer is the head of Renovia company as well as the co-founder together with other experts. His primary goal at the company is to invent new therapeutic and diagnostic treatments for pelvic disorders. According to the research conducted more than 250 million women suffer from various pelvic disorders particular Urinary incontinence but that are either ashamed or unable to afford treatments hence live with this discomforting condition. Marc Beer has come to the rescue by raising $32 million to establish a Boston based medical center.
Boston- based medical center has a team of experts to research and invent more than four other treatments for pelvic disorders. $10 million was used for the venture debt while the additional money was invested in the new medical center. The first product for Renovia company was the Leva device made with advanced technology to strengthen pelvic wall muscles as well as reducing stress in women. Leva product was approved by FDA in April to meet the needs of many women.
Longwood Company has invested in Renovia to fund Series B round to establish more treatments. Over the years Longwood company has been focused on investing in health sector funding various projects. According to Marc Beer, this partnership will lead to sharing proprietary sensor technology and innovative ideas to form a digital platform for the patients. The platform is estimated to provide valuable information to the patients on the new treatment methods, lower long term costs as well as the reasons they should seek medical support. Series B project has already transformed the lives of many women across the globe as it provides solutions that are effective at affordable costs. Learn more: https://people.equilar.com/bio/marc-beer-aegerion-pharmaceuticals-/salary/78453